JP5380078B2 - アレナウイルス感染の治療のための抗ウイルス薬剤 - Google Patents

アレナウイルス感染の治療のための抗ウイルス薬剤 Download PDF

Info

Publication number
JP5380078B2
JP5380078B2 JP2008557379A JP2008557379A JP5380078B2 JP 5380078 B2 JP5380078 B2 JP 5380078B2 JP 2008557379 A JP2008557379 A JP 2008557379A JP 2008557379 A JP2008557379 A JP 2008557379A JP 5380078 B2 JP5380078 B2 JP 5380078B2
Authority
JP
Japan
Prior art keywords
substituted
phenyl
methoxy
benzimidazol
benzyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2008557379A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009528368A (ja
JP2009528368A5 (cg-RX-API-DMAC7.html
Inventor
フルービー,デニス・イー
ボルケン,トーベ
アンベルグ,ショーン
ダイ,ドンチェン
Original Assignee
サイガ・テクノロジーズ・インコーポレーテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by サイガ・テクノロジーズ・インコーポレーテッド filed Critical サイガ・テクノロジーズ・インコーポレーテッド
Publication of JP2009528368A publication Critical patent/JP2009528368A/ja
Publication of JP2009528368A5 publication Critical patent/JP2009528368A5/ja
Application granted granted Critical
Publication of JP5380078B2 publication Critical patent/JP5380078B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2008557379A 2006-03-02 2007-03-02 アレナウイルス感染の治療のための抗ウイルス薬剤 Expired - Fee Related JP5380078B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US77810706P 2006-03-02 2006-03-02
US60/778,107 2006-03-02
PCT/US2007/005263 WO2007103111A2 (en) 2006-03-02 2007-03-02 Antiviral drugs for treatment of arenavirus infection

Publications (3)

Publication Number Publication Date
JP2009528368A JP2009528368A (ja) 2009-08-06
JP2009528368A5 JP2009528368A5 (cg-RX-API-DMAC7.html) 2010-07-29
JP5380078B2 true JP5380078B2 (ja) 2014-01-08

Family

ID=38475385

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008557379A Expired - Fee Related JP5380078B2 (ja) 2006-03-02 2007-03-02 アレナウイルス感染の治療のための抗ウイルス薬剤

Country Status (8)

Country Link
US (2) US7872037B2 (cg-RX-API-DMAC7.html)
EP (1) EP1988776B1 (cg-RX-API-DMAC7.html)
JP (1) JP5380078B2 (cg-RX-API-DMAC7.html)
AP (1) AP2267A (cg-RX-API-DMAC7.html)
CA (1) CA2651943C (cg-RX-API-DMAC7.html)
ES (1) ES2395101T3 (cg-RX-API-DMAC7.html)
WO (1) WO2007103111A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200807507B (cg-RX-API-DMAC7.html)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007351866C1 (en) * 2003-06-20 2013-07-25 Siga Technologies, Inc. Chemicals, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases
US7687641B2 (en) * 2003-06-20 2010-03-30 Siga Technologies, Inc. Chemicals, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases
US8530509B2 (en) 2003-06-20 2013-09-10 Siga Technologies, Inc. Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases
WO2006062898A2 (en) * 2004-12-06 2006-06-15 Siga Technologies, Inc. Compounds and methods for treating hemorrhagic fever viruses
US7994221B2 (en) 2004-12-06 2011-08-09 Siga Technologies, Inc. Sulfonyl semicarbazides, carbonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses
US8410149B2 (en) 2004-12-06 2013-04-02 Siga Technologies Inc. Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses
CA2640687A1 (en) 2006-02-01 2007-10-25 Siga Technologies, Inc. Anti-arenaviral compounds
US8791110B2 (en) 2006-02-01 2014-07-29 Siga Technologies, Inc. Anti-arenaviral compounds
EP1988776B1 (en) 2006-03-02 2012-08-08 Siga Technologies, Inc. Antiviral drugs for treatment of arenavirus infection
US8871746B2 (en) 2006-03-02 2014-10-28 Kineta Four, LLC Antiviral drugs for treatment of arenavirus infection
US7977365B2 (en) * 2006-03-02 2011-07-12 Siga Technologies, Inc. Antiviral drugs for treatment of arenavirus infection
EP1988884A4 (en) 2006-03-02 2009-09-30 Siga Technologies Inc ANTIVIRAL DRUGS FOR THE TREATMENT OF ARENAVIRUS INFECTIONS
US20080033755A1 (en) * 2006-06-07 2008-02-07 Krusz John C Medical treatment modality for headache, pain, and other medical disorders
CN101034257B (zh) * 2007-04-06 2010-09-08 上海复旦天臣新技术有限公司 用于全息记录的感光薄膜及其制备方法
PH12012502343A1 (en) * 2007-05-23 2013-06-17 Siga Tech Inc Antiviral drugs for treatment or prevention of dengue infection
WO2009025743A2 (en) * 2007-08-17 2009-02-26 University Of Massachusetts Medical School Use of trail compositions as antiviral agents
CA2698075C (en) * 2007-08-27 2016-04-12 Siga Technologies, Inc. Antiviral drugs for treatment of arenavirus infection
US8940730B2 (en) 2007-09-18 2015-01-27 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions of treating a Flaviviridae family viral infection
WO2009039248A2 (en) * 2007-09-18 2009-03-26 Stanford University Methods of treating a flaviviridae family viral infection and compositions for treating a flaviviridae family viral infection
US9149463B2 (en) 2007-09-18 2015-10-06 The Board Of Trustees Of The Leland Standford Junior University Methods and compositions of treating a Flaviviridae family viral infection
US9101628B2 (en) 2007-09-18 2015-08-11 The Board Of Trustees Of The Leland Stanford Junior University Methods and composition of treating a flaviviridae family viral infection
JP5795714B2 (ja) * 2008-01-15 2015-10-14 シガ・テクノロジーズ・インコーポレーテッド アレナウイルス感染症の治療のための抗ウイルス薬
CN102448458B (zh) 2009-03-18 2015-07-22 小利兰·斯坦福大学理事会 治疗黄病毒科病毒感染的方法和组合物
US8609663B2 (en) * 2009-11-18 2013-12-17 University Of Massachusetts Compounds for modulating TLR2
PE20170944A1 (es) 2010-03-23 2017-07-13 Siga Tech Inc Formas polimorficas de st-246 y metodos de preparacion
MX359989B (es) * 2012-02-17 2018-10-18 Siga Tech Inc Fármacos antivirales para el tratamiento de la infección por arenavirus.
US11352328B2 (en) 2016-07-12 2022-06-07 Arisan Therapeutics Inc. Heterocyclic compounds for the treatment of arenavirus
CN108272838A (zh) * 2018-03-23 2018-07-13 三峡大学 小花清风藤提取物及其提取方法和应用
US12419865B2 (en) 2018-12-06 2025-09-23 Arisan Therapeutics Inc. Compounds for the treatment of arenavirus infection
US20220259180A1 (en) * 2019-06-06 2022-08-18 Matthew Frieman Broad spectrum antiviral compounds targeting the ski complex

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4492708A (en) * 1982-09-27 1985-01-08 Eli Lilly And Company Antiviral benzimidazoles
EP1206265B1 (en) * 1999-06-30 2003-11-12 Merck & Co., Inc. Src kinase inhibitor compounds
US20030134853A1 (en) * 2001-09-26 2003-07-17 Priestley Eldon Scott Compounds useful for treating hepatitis C virus
ATE457025T1 (de) * 2002-05-23 2010-02-15 Cytopia Res Pty Ltd Kinaseinhibitoren
AU2007351866C1 (en) 2003-06-20 2013-07-25 Siga Technologies, Inc. Chemicals, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases
US7687641B2 (en) * 2003-06-20 2010-03-30 Siga Technologies, Inc. Chemicals, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases
US7737168B2 (en) 2003-06-20 2010-06-15 Siga Technologies, Inc. Compounds, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases
BRPI0413234A (pt) * 2003-08-01 2006-10-03 Genelabs Tech Inc derivados de imidazola bicìclica contra flaviviridae
DE10348023A1 (de) 2003-10-15 2005-05-19 Imtm Gmbh Neue Alanyl-Aminopeptidasen-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen
RU2006128606A (ru) * 2004-01-30 2008-03-10 Пфайзер Инк. (US) Терапевтические комбинации
US7994221B2 (en) 2004-12-06 2011-08-09 Siga Technologies, Inc. Sulfonyl semicarbazides, carbonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses
WO2006062898A2 (en) 2004-12-06 2006-06-15 Siga Technologies, Inc. Compounds and methods for treating hemorrhagic fever viruses
CA2626846A1 (en) 2005-11-03 2007-05-18 Redpoint Bio Corporation Hydrazone derivatives and uses thereof
CA2640687A1 (en) 2006-02-01 2007-10-25 Siga Technologies, Inc. Anti-arenaviral compounds
EP1988776B1 (en) 2006-03-02 2012-08-08 Siga Technologies, Inc. Antiviral drugs for treatment of arenavirus infection
EP1988884A4 (en) * 2006-03-02 2009-09-30 Siga Technologies Inc ANTIVIRAL DRUGS FOR THE TREATMENT OF ARENAVIRUS INFECTIONS
US7977365B2 (en) * 2006-03-02 2011-07-12 Siga Technologies, Inc. Antiviral drugs for treatment of arenavirus infection
PH12012502343A1 (en) 2007-05-23 2013-06-17 Siga Tech Inc Antiviral drugs for treatment or prevention of dengue infection
CA2698075C (en) 2007-08-27 2016-04-12 Siga Technologies, Inc. Antiviral drugs for treatment of arenavirus infection
JP5795714B2 (ja) 2008-01-15 2015-10-14 シガ・テクノロジーズ・インコーポレーテッド アレナウイルス感染症の治療のための抗ウイルス薬
CN102056483A (zh) 2008-06-03 2011-05-11 西佳技术公司 用于治疗或预防登革病毒感染的小分子抑制剂

Also Published As

Publication number Publication date
CA2651943C (en) 2015-06-30
JP2009528368A (ja) 2009-08-06
WO2007103111A8 (en) 2012-04-12
EP1988776B1 (en) 2012-08-08
ES2395101T3 (es) 2013-02-08
US20070254934A1 (en) 2007-11-01
US7872037B2 (en) 2011-01-18
WO2007103111A3 (en) 2007-12-21
AP2267A (en) 2011-08-02
US20110172281A1 (en) 2011-07-14
EP1988776A2 (en) 2008-11-12
EP1988776A4 (en) 2010-09-01
US8629170B2 (en) 2014-01-14
ZA200807507B (en) 2009-08-26
AP2008004594A0 (en) 2008-08-31
WO2007103111A2 (en) 2007-09-13
CA2651943A1 (en) 2007-09-13

Similar Documents

Publication Publication Date Title
JP2009528368A (ja) アレナウイルス感染の治療のための抗ウイルス薬剤
JP5393679B2 (ja) アレナウイルス感染症を治療するための抗ウイルス薬
JP2009528367A (ja) アレナウイルス感染の治療のための抗ウイルス薬剤
JP5795714B2 (ja) アレナウイルス感染症の治療のための抗ウイルス薬
JP5854841B2 (ja) デングウイルス感染を治療及び予防するためのチエノピリジン誘導体類
US7977365B2 (en) Antiviral drugs for treatment of arenavirus infection
JP2010526025A (ja) スルホニルセミカルバジド、カルボニルセミカルバジド、セミカルバジドおよび尿素、その薬学的組成物、ならびにアレナウイルスに関連する感染を含む、出血熱ウイルスを治療するための方法。
JP2008524119A (ja) アレナウイルスに関連した感染をはじめとする出血熱ウイルスを処置するための、スルホニルセミカルバジド、セミカルバジドおよび尿素、その医薬組成物および方法
US8871746B2 (en) Antiviral drugs for treatment of arenavirus infection

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20100226

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100614

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120810

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20121112

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20121119

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20121210

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20121217

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20130109

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20130117

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130212

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130308

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130604

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130723

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130726

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20130902

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20130930

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees